Results from 306 B, a large phase III study demonstrating improvement in dizziness / lightheadness, the main symptom of NOH and confirming findings from the previous 301 study, was included in the resubmitted NDA.
Chelsea Therapeutics had initially submitted an NDA for Northera in Sep 2011. However, the company received a complete response letter (CRL) in Mar 2012. In the CRL, the FDA recommended that Chelsea Therapeutics should conduct and submit data from an additional positive study supporting efficacy in the 301 study. The company was also asked to design a study which would demonstrate durability of effect over a 2- to 3-month period.
Top Solar Stocks To Own For 2015: Meadwestvaco Corporation (MWV)
MeadWestvaco Corporation (MWV) provides packaging solutions to the healthcare, personal care and beauty, food, beverage, home and garden, tobacco, and commercial print industries worldwide. The company?s Packaging Resources segment produces bleached paperboard, Coated Natural Kraft paperboard, and linerboard. Its Consumer Solutions segment designs and produces multi-pack cartons and packaging systems primarily for the beverage take-home and tobacco market. In addition, it offers a range of converting and consumer packaging solutions, including printed plastic packaging and injection-molded products used for personal care, beauty, and pharmaceutical products; and dispensing and sprayer systems for personal care, beauty, healthcare, fragrance, and home and garden markets. In addition, this segment has a pharmaceutical packaging contract with a mass-merchant, and manufactures equipment that is leased or sold to its beverage and dairy customers to package their products. The c ompany?s Consumer & Office Products segment manufactures, sources, markets, and distributes school and office products, time-management products, and envelopes in North America and Brazil through both retail and commercial channels. Its Specialty Chemicals segment manufactures, markets, and distributes specialty chemicals derived from sawdust and other byproducts of the papermaking process in North America, South America, and Asia. Its products include activated carbon used in emission control systems for automobiles and trucks, as well as for water and food purification applications, and performance chemicals used in printing inks, asphalt paving, adhesives, and lubricants for the agricultural, paper, and petroleum industries. MWV?s Community Development and Land Management segment involves in real estate development, forestry operations, and leasing activities. MeadWestvaco Corporation was founded in 1888 and is based in Glen Allen, Virginia.
Advisors' Opinion:- [By Eric Volkman]
MeadWestvaco (NYSE: MWV ) is continuing to deliver payouts for its shareholders. The company has declared a fresh quarterly dividend of $0.25 per share, to be handed out on September 3 to shareholders of record as of August 31.�That amount matches each of the company's regular quarterly payouts stretching back to late 2010. Prior to that, it paid $0.23 per share.
- [By Lauren Pollock]
MeadWestvaco Corp.(MWV) expanded its cost-cutting efforts and said it plans to simplify the structure of its packaging businesses, as it strives to improve its performance.
- [By Ben Levisohn]
When you’re stock has been lagging the S&P 500, sometimes drastic action must be followed by even more drastic action. Case in point: MeadWestvaco (MWV), which announced a program of cost cutting on the heels of one announced last year.
Best Electric Utility Companies To Watch For 2014: Location Based Technologies Inc (LBAS)
Location Based Technologies, Inc. (LBT), incorporated on April 20, 2006, designs, develops, and sells personal, pet, and vehicle locator devices and services including PocketFinder People, PocketFinder Pets and PocketFinder Vehicles. The Company markets and sells consumer and commercial location devices and services. Its devices utilize Assisted Global Positioning System (A-GPS) and General Packet Radio Service (GPRS) technologies in conjunction with its technologies designed to enhance the families to interact and stay connected around the world. The Company is a developer of the PocketFinder family of products and the PocketFinder Network. The PocketFinder family of products includes the PocketFinder People, PocketFinder Vehicle, PocketFinder Pets, PocketFinder Luggage, PocketFinder Mobile and PocketFinder Fleet. The PocketFinder is a small location device that enables a user to locate a device, person, or pet, at anytime from almost anywhere. PocketFinder personal locator devices are wireless.
The Company generate revenue by selling its products and charging customers an ongoing service fee, for which it offers monthly and annual subscription plans. The Company�� product, PocketFinder, is a small, waterproof and wireless location device that enables users to locate anyone or anything they care about, from a computer or Web-enabled device. Its products deliver critical information to users, such as: device location, longitude, latitude, heading speed and 60 days of location history. This information can be viewed passively through a user�� account or can be sent to a user via email or push notification if the user sets an alert. The target markets for the PocketFinder include: young children, seniors, people with special needs and people who need to track valuable assets such as luggage or sporting equipment. In addition to the PocketFinder, it also sell the PocketFinder Pet and the PocketFinder Vehicle products. The PocketFinder Pet is designed for pets weighing 15 pounds or more,! and it markets the PocketFinder Vehicle to families with new drivers, car enthusiasts, motorcycle owners, watercraft owners and business fleets. The PocketFinder Vehicle attaches directly to a battery or fuse box, so it has a constant supply of power. All PocketFinder products operate on the same user interface, which enables its customers receive the same features, functionality and user-experience, regardless of which product they own. To access their account or locate their devices, users can logon to the Company�� Website at www.pocketfinder.com or use its native iPhone, iPad or Android Apps.
The Company�� products are sold through various brick-and-mortar and online retailers and through its Website. It provides customer service and support in the United States through existing call centers owned by Affinitas. It provides wireless location based solutions for global positioning products along with its friendly user interface software system. PocketFinder and PocketFinder Vehicle devices are being sold in the United States and in Canada through the Apple Online Store and Apple Retail Stores. PocketFinder devices for Pets are available for purchase on its Website.
The Company competes with Geospatial Platform Providers, Application Developers, Garmin�� GTU-10, Qualcomm�� Tagg, Lo-Jack, SpotLight, Fleetmatics, NetworkFleet, and Qualcomm.
Advisors' Opinion:- [By CRWE]
Today, LBAS�remains (0.00%) +0.000 at $.132 with 9,470 shares in movement thus far (ref. google finance Delayed: 9:47AM EDT June 20, 2013).
Location Based Technologies, Inc. previously received FCC and IC certification for its versatile LBT-886 device. These certifications are necessary before devices can be sold to consumers throughout the US and Canada.
The LBT-886 device is available for manufacture in a 2G or 3G variant. The 3G penta-band variant will enable the device to function in countries which only operate on the 3G spectrum, such as Australia, South Korea, Japan and some areas of Canada. This global tracking solution also delivers additional features such as various environmental sensors or comes with an attachment with special capability designed to meet lone-worker or personnel security requirements
- [By CRWE]
Today, LBAS has shed (-7.69%) -0.010 at $.120 with 95,100 shares in play thus far (ref. google finance Delayed: 12:21PM EDT August 15, 2013).
Location Based Technologies, Inc. previously reported it has signed a distribution agreement with Beijing Lava Technology Co. Ltd., an Apple approved distributor for its online, brick and mortar stores, and authorized distributors in Asia. The agreement is one of the final steps preceding the launch of LBT�� GPS products into the Asian markets. Beijing Lava Technology Co. Ltd. serves China, Singapore, Japan, Korea, Taiwan, Malaysia, and Indonesia.
LBT estimates that it will begin selling its PocketFinder devices in Singapore through Apple�� online store and authorized distributors in the near future with other Asian countries to follow thereafter.
- [By CRWE]
Today, LBAS surged (+10.27%) up +0.015 at $.160 with�39,780 shares in play thus far (ref. google finance Delayed: 11:41AM EDT July 5, 2013).
Location Based Technologies, Inc. and EE, Ltd., the U.K.�� most advanced communications company, have previously entered into a purchase agreement which will allow LBT to embed EE SIM technology into LBT�� world�� best GPS products for immediate purchase throughout Europe and in additional areas around the world.
EE�� relationship with LBT continues to grow. The companies began their relationship earlier this year when EE launched PocketFinder Personal GPS Locators in their London flagship stores (https://explore.ee.co.uk/pocket-finder). With this latest agreement, LBT now has the capability to sell devices into Europe using a local SIM, thereby greatly reducing the monthly service fee charged to customers.
Best Electric Utility Companies To Watch For 2014: Mettler-Toledo International Inc. (MTD)
Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; automated chemistry solutions used in drug and chemical compound discovery and development; and metal detection and other end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. Its laboratory instruments include laboratory balances, pipettes, titrators, thermal analysis systems, and other analytical instruments comprising pH meters, density and refractometry instruments, moisture analyzers, as well as laboratory software, automated chemistry solutions, and process analytic instruments. The company�s industrial solutions comprise in dustrial weighing instruments, industrial terminals, automatic identification and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail solutions consist of multiple weighing and food labeling solutions, such as stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force, as well as through indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Mettler-Toledo International (NYSE: MTD ) , whose recent revenue and earnings are plotted below.
Best Electric Utility Companies To Watch For 2014: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV). - [By Michael Douglass and David Williamson]
Shares of�Pernix Therapeutics� (NASDAQ: PTX ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to�GlaxoSmithKline's (NYSE: GSK ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.
No comments:
Post a Comment